Item 8.01. Other Events.

On January 11, 2021, Rubius Therapeutics, Inc. (the "Company") provided an operational update and outlined its 2021 objectives, which the Company will be presenting at the 39th Annual J.P. Morgan Healthcare Conference during the week of January 11, 2021 (the "J.P. Morgan Conference"). A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

A copy of the Company's presentation to be shared with investors and others from time to time beginning at the J.P. Morgan Conference (the "Investor Presentation") is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. The information contained in the Investor Presentation should be considered in the context of the Company's filings with the Securities and Exchange Commission and other public announcements the Company may make by press release or otherwise from time to time. Information concerning risk factors affecting the Company's business can be found in its periodic filings with the Securities and Exchange Commission at www.sec.gov. The Investor Presentation is current as of January 11, 2021, and the Company disclaims any obligation to update the Investor Presentation after such date.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.



Exhibit
No.                                          Description

  99.1       Press Release issued by Rubius Therapeutics, Inc. on January 11, 2021.
  99.2       Investor Presentation of Rubius Therapeutics, Inc., dated January 11, 2021.
104        Cover Page Interactive Data File (embedded within the Inline XBRL document).




                                       2

© Edgar Online, source Glimpses